Company Filing History:
Years Active: 2015-2023
Title: Yasushi Okuno: Innovator in Disease Treatment and Compound Interaction
Introduction
Yasushi Okuno is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the fields of disease treatment and compound interaction estimation. With a total of 2 patents, his work focuses on advancing therapeutic methods and improving the efficiency of compound screening.
Latest Patents
One of Yasushi Okuno's latest patents is titled "Efficacy determination markers in disease treatment by PD-1 signal inhibitor." This invention provides markers for assessing the efficacy of therapy with a PD-1 signal inhibitor at an early stage. The patent utilizes biomarkers related to metabolic changes in T cells, including intestinal flora-related metabolites and energy metabolism-related metabolites. These indicators help predict the effectiveness of the therapy.
Another notable patent is "Estimation of protein-compound interaction and rational design of compound library based on chemical genomic information." This invention outlines a data processing method for estimating compound-protein interactions by integrating chemical substance information and biological data. The method employs multivariable analysis techniques or machine learning to enhance the correlation between different chemical substance groups.
Career Highlights
Yasushi Okuno is affiliated with Kyoto University, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential impact on therapeutic strategies and drug discovery.
Collaborations
Yasushi has collaborated with notable colleagues, including Kei Taneishi and Gozoh Tsujimoto. Their combined expertise contributes to the advancement of research and innovation in their respective areas.
Conclusion
Yasushi Okuno's contributions to the fields of disease treatment and compound interaction estimation highlight his role as an influential inventor. His innovative patents pave the way for advancements in therapeutic efficacy and drug discovery.